Abstract
The Social Security Act establishes several criteria that must be satisfied in order for an item or service to be eligible for reimbursement under the Medicare program. These threshold Medicare coverage criteria include the requirement that the item or service be reasonable and necessary for the diagnosis or treatment of an illness or injury or to improve the functioning of a malformed body member. Administrators of the Medicare program have generally held that experimental therapies are not reasonable and necessary. This interpretation of the reasonable and necessary criteria traditionally precluded Medicare coverage for services provided to beneficiaries as part of clinical investigations. Denying Medicare reimbursement for investigational interventions and costs related thereto created a barrier to Medicare beneficiaries’ participation in clinical trials. This posed a dual problem. First, in the short term, it could deny Medicare beneficiaries access to potentially useful therapies available in the clinical trial context. Second, limited enrollment of Medicare beneficiaries in clinical trials hindered collection of sufficient evidence to demonstrate a new therapy’s effectiveness for use in the Medicare population.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
See “Medicare Coverage-Clinical Trials: Final National Coverage Decision,” available at http://www.cms.hhs.gov/coverage/8d2.asp and “Medicare Coverage-Clinical Trials: Program Memorandum,” available at http://www.cms.hhs.gov/coverage/8d3.a
See “Implementation of the FDA/HCFA Interagency Agreement Regarding Reimbursement of Investigational Devices,” September 15, 1995 (D95-2). Available at http://www.fda.gov/cdrh/d952.html.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Taitsman, J.K. (2006). Overview of Medicare Coverage of Clinical Trials. In: Becker, K.M., Whyte, J.J. (eds) Clinical Evaluation of Medical Devices. Humana Press. https://doi.org/10.1007/978-1-59745-004-1_8
Download citation
DOI: https://doi.org/10.1007/978-1-59745-004-1_8
Publisher Name: Humana Press
Print ISBN: 978-1-58829-422-7
Online ISBN: 978-1-59745-004-1
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)